Overexpression of SIRT3 disrupts mitochondrial proteostasis and cell cycle progression

Xiaofei Wang; Haiping Tang; Yuling Chen; Binghuan Chi; Shiyu Wang; Yang Lv; Di Wu; Renshan Ge; Haiteng Deng

doi:10.1007/s13238-016-0251-z

PDF(581 KB)

Protein Cell ›› 2016, Vol. 7 ›› Issue (4) : 295-299. DOI: 10.1007/s13238-016-0251-z

LETTER

Overexpression of SIRT3 disrupts mitochondrial proteostasis and cell cycle progression

Author information +

History +

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾

Xiaofei Wang, Haiping Tang, Yuling Chen, Binghuan Chi, Shiyu Wang, Yang Lv, Di Wu, Renshan Ge, Haiteng Deng. Overexpression of SIRT3 disrupts mitochondrial proteostasis and cell cycle progression. Protein Cell, 2016, 7(4): 295‒299 https://doi.org/10.1007/s13238-016-0251-z

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Alhazzazi TY, Kamarajan P, Verdin E, Kapila YL (2011) SIRT3 and cancer: tumor promoter or suppressor? Biochim Biophys Acta 1816:80–88

[2]	Ashraf N, Zino S, Macintyre A, Kingsmore D, Payne AP, George WD, Shiels PG (2006) Altered sirtuin expression is associated with node-positive breast cancer. Br J Cancer 95:1056–1061 CrossRef Google scholar

[3]	Carracedo A, Cantley LC, Pandolfi PP (2013) Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer 13:227–232 CrossRef Google scholar

[4]	Cohen HT, McGovern FJ (2005) Renal-cell carcinoma. N Engl J Med 353:2477–2490 CrossRef Google scholar

[5]	Debeb BG, Zhang X, Krishnamurthy S, Gao H, Cohen E, Li L, Rodriguez AA, Landis MD, Lucci A, Ueno NT (2010) Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells. Mol Cancer 9:180 CrossRef Google scholar

[6]	Finley LW, Haigis MC (2012) Metabolic regulation by SIRT3: implications for tumorigenesis. Trends Mol Med 18:516–523 CrossRef Google scholar

[7]

Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM (2010) SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 17:41–52

CrossRef Google scholar

[8]	McDonnell E, Peterson BS, Bomze HM, Hirschey MD (2015) SIRT3 regulates progression and development of diseases of aging. Trends Endocrinol Metab 26:486–492 CrossRef Google scholar

[9]	Papa L, Germain D (2014) SirT3 regulates the mitochondrial unfolded protein response. Mol Cell Biol 34:699–710 CrossRef Google scholar

[10]	Qiu X, Brown K, Hirschey MD, Verdin E, Chen D (2010) Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 12:662–667 CrossRef Google scholar

[11]	Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501–1512 CrossRef Google scholar

[12]	Verdin E, Hirschey MD, Finley LW, Haigis MC (2010) Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem Sci 35:669–675 CrossRef Google scholar

[13]	Yang Y, Chen KY, Tong Q (2011) Murine Sirt3 protein isoforms have variable half-lives. Gene 488:46–51 CrossRef Google scholar

[14]	Yu W, Dittenhafer-Reed KE, Denu JM (2012) SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status. J Biol Chem 287:14078–14086 CrossRef Google scholar

RIGHTS & PERMISSIONS

2014 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.